Evidence map›Paper›PMID 38244122›Full record

ReviewSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2024

Considerations for establishing and maintaining international research collaboration: the example of chemotherapy-induced peripheral neurotoxicity (CIPN)-a white paper.

Paola Alberti, Andreas A Argyriou, Jordi Bruna, M Imad Damaj, Sara Faithfull, Alice Harding, Ahmet Hoke, Robert Knoerl, Noah Kolb, Tiffany Li and 5 more

Erratum issuedAbstract readReviewConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Review in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Paola AlbertiUniversity of Milano-Bicocca, School of Medicine and Surgery, Monza, Italy.ORCID https://orcid.org/0000-0001-6106-6183
Andreas A ArgyriouNeurology Department, Agios Andreas General Hospital, Patras, Greece.ORCID https://orcid.org/0000-0003-2131-7114
Jordi BrunaHospital Universitari de Bellvitge, Neuro-Oncology Unit, Institut Catala d'Oncologia (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain.ORCID https://orcid.org/0000-0001-6895-5047
M Imad DamajDepartment of Pharmacology and Toxicology and Translational Research Initiative for Pain and Neuropathy, Virginia Commonwealth University, Richmond, VA, USA.
Sara FaithfullTrinity College Dublin, School of Medicine, Dublin, Ireland.ORCID https://orcid.org/0000-0002-7951-0243
Alice HardingUniversity of Alabama at Birmingham, Office of Sponsored Programs, Birmingham, AL, USA.
Ahmet HokeDepartment of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, USA.ORCID https://orcid.org/0000-0003-1215-3373
Robert KnoerlDepartment of Health Behavior and Biological Sciences, University of Michigan School of Nursing, Ann Arbor, MI, USA.ORCID https://orcid.org/0000-0002-6996-5068
Noah KolbDepartment of Neurological Sciences, University of Vermont Robert Larner College of Medicine, Burlington, VT, USA.ORCID https://orcid.org/0000-0003-2651-2349
Tiffany LiFaculty of Medicine and Health, University of Sydney, Brain and Mind Centre and School of Medical Sciences, Sydney, Australia.ORCID https://orcid.org/0000-0003-1138-1489
Susanna B ParkFaculty of Medicine and Health, University of Sydney, Brain and Mind Centre and School of Medical Sciences, Sydney, Australia.ORCID https://orcid.org/0000-0003-0218-4707
Nathan P StaffDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.ORCID https://orcid.org/0000-0001-6760-3859
Stefano TamburinDepartment of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.ORCID https://orcid.org/0000-0002-1561-2187
Simone ThomasDepartment of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Ellen Lavoie SmithDepartment of Acute, Chronic & Continuing Care, University of Alabama at Birmingham School of Nursing, Birmingham, AL, USA. esmith3@uab.edu.ORCID https://orcid.org/0000-0002-6519-6636

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis white paper provides guidance regarding the process for establishing and maintaining international collaborations to conduct oncology/neurology-focused chemotherapy-induced peripheral neurotoxicity (CIPN) research.

methodsAn international multidisciplinary group of CIPN scientists, clinicians, research administrators, and legal experts have pooled their collective knowledge regarding recommendations for establishing and maintaining international collaboration to foster advancement of CIPN science.

resultsExperts provide recommendations in 10 categories: (1) preclinical and (2) clinical research collaboration; (3) collaborators and consortiums; (4) communication; (5) funding; (6) international regulatory standards; (7) staff training; (8) data management, quality control, and data sharing; (9) dissemination across disciplines and countries; and (10) additional recommendations about feasibility, policy, and mentorship.

conclusionRecommendations to establish and maintain international CIPN research collaboration will promote the inclusion of more diverse research participants, increasing consideration of cultural and genetic factors that are essential to inform innovative precision medicine interventions and propel scientific discovery to benefit cancer survivors worldwide. RELEVANCE TO INFORM RESEARCH POLICY: Our suggested guidelines for establishing and maintaining international collaborations to conduct oncology/neurology-focused chemotherapy-induced peripheral neurotoxicity (CIPN) research set forth a challenge to multinational science, clinical, and policy leaders to (1) develop simple, streamlined research designs; (2) address logistical barriers; (3) simplify and standardize regulatory requirements across countries; (4) increase funding to support international collaboration; and (5) foster faculty mentorship.

Indexed as

Antineoplastic AgentsCancer SurvivorsNeurotoxicity SyndromesPeripheral Nervous System DiseasesAdministrative PersonnelHumansAntineoplastic AgentsChemotherapy-induced peripheral neurotoxicityInternational collaborationResearch

Identifiers

PMID38244122
PMCPMC10799817

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.